Inventor · disambiguated record
Gregory A. Reichard
Also filed as: REICHARD GREGORY · REICHARD GREGORY A · REICHARD GREGORY ADAM
23 granted patents·4 pending applications·419 citations·filing 1996–2017
96Inventor score
Top patents by PatentIndex Score
27 records- 0194US7049320B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted May 23, 2006·54 cites·17 claims
- 0294US6635630B2Selective neurokinin antagonistsSCHERING CORP·Filed 2002·Granted Oct 21, 2003·41 cites·9 claims
- 0392US7902366B2NK1 antagonistsOPKO HEALTH INC·Filed 2006·Granted Mar 8, 2011·19 cites·19 claims
- 0490US5789422ASubstituted arylalkylamines as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Aug 4, 1998·51 cites·12 claims
- 0588US8796299B2NK1 antagonistsOPKO HEALTH INC·Filed 2012·Granted Aug 5, 2014·9 cites·15 claims
- 0687US8273895B2NK1 antagonistsPALIWAL SUNIL·Filed 2010·Granted Sep 25, 2012·12 cites·3 claims
- 0787US6436928B1Selective neurokinin antagonistsSCHERING CORP·Filed 2000·Granted Aug 20, 2002·17 cites·23 claims
- 0886US5696267ASubstituted oximes, hydrazones and olefins as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Dec 9, 1997·70 cites·23 claims
- 0985US6204265B1Substituted oximes and hydrazones as neurokinin antagonistsSCHERING CORP·Filed 1999·Granted Mar 20, 2001·31 cites·13 claims
- 1084US7122677B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted Oct 17, 2006·26 cites·23 claims
- 1180US7041682B2NK1 antagonistsSCHERING CORP·Filed 2003·Granted May 9, 2006·14 cites·20 claims
- 1276US6878732B2NK1 antagonistsSCHERING CORP·Filed 2003·Granted Apr 12, 2005·10 cites·26 claims
- 1373US7659394B2Substituted morpholine compounds for the treatment of central nervous system disordersPFIZER·Filed 2005·Granted Feb 9, 2010·4 cites·10 claims
- 1471US6063926ASubstituted oximes as neurokinin antagonistsSCHERING CORP·Filed 1998·Granted May 16, 2000·14 cites·7 claims
- 1571US5945428ASubstituted oximes, hydrazones and olefins as neurokinin antagonistsSCHERING CORP·Filed 1997·Granted Aug 31, 1999·15 cites·12 claims
- 1669US5840725ASubstituted oximes, hydrazones and olefins as neurokinin antagonistsSCHERING CORP·Filed 1997·Granted Nov 24, 1998·26 cites·20 claims
- 1765US9334246B2Substituted triazines for malaria treatment and chemoprophylaxisUS OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF THE WALTER REED ARMY INST OF·Filed 2014·Granted May 10, 2016·1 cites·25 claims
- 1864US9688693B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Jun 27, 2017·0 cites·8 claims
- 1964US6534502B2Substituted oximes and hydrazones as neurokinin antagonistsSCHERING CORP·Filed 2001·Granted Mar 18, 2003·2 cites·7 claims
- 2063US6403582B2Substituted oximes and hydrazones as neurokinin antagonistsSCHERING CORP·Filed 2001·Granted Jun 11, 2002·2 cites·5 claims
- 2161US2017283434A1Nk1 antagonistsOPKO HEALTH INC·Filed 2017·Application pending·0 cites
- 2251US6569872B1Use of neurokinin receptor antagonists to treat androgen-dependent diseasesSCHERING CORP·Filed 2002·Granted May 27, 2003·1 cites·30 claims
- 2351US2006094720A1NK1 antagonistsSHIH NENG-YANG·Filed 2005·Application pending·0 cites
- 2445US2005096350A1Halo substituted benzo[b]thiophenes as therapeutic agentsFiled 2004·Application pending·0 cites
- 2544US7498438B2Fused ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Mar 3, 2009·0 cites·24 claims
- 2637US2008255162A1Pyrrolyl Substituted Pyrido[2,3-D]Pyrimidin-7-Ones and Derivatives Thereof as Therapeutic AgentsWARNER LAMBERT CO·Filed 2005·Application pending·0 cites
- 2732US9700562B2Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxisTHE US SECRETARY OF THE ARMY ON BEHALF OF THE WALTER REED ARMY INST OF RES·Filed 2016·Granted Jul 11, 2017·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →